Joseph C Galante insider trades
Open-market stock purchases and sales by Joseph C Galante, Director at Cumberland Pharmaceuticals Inc, from SEC Form 4 filings since Feb 9, 2015.
Track record: 100% of 390 scored buys are up 5% or more since purchase, averaging +164%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 18, 2026 | CPIX Cumberland Pharmaceuticals Inc | Bought (not open market) | $5K |